n South African Medical Journal - Access to flucytosine for HIV-infected patients with cryptococcal meningitis - an urgent need : correspondence
|Article Title||Access to flucytosine for HIV-infected patients with cryptococcal meningitis - an urgent need : correspondence|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||South African Medical Journal|
|Affiliations||1 National Health Laboratory Service, 2 University of the Witwatersrand, 3 University of the Witwatersrand, 4 University of Cape Town and 5 Imperial College London, UK|
|Publication Date||Sep 2014|
|Pages||594 - 595|
The addition of oral flucytosine to an amphotericin B-containing induction regimen for HIV-associated cryptococcal meningitis (CM) is associated with improved fungal clearance and a 39% reduction in 10-week mortality. Owing to the unacceptably high mortality associated with CM, access to flucytosine needs to be prioritised in South Africa (SA), together with interventions such as earlier detection of cryptococcal disease. The World Health Organization (WHO) recommended amphotericin B and flucytosine as the preferred induction regimen in rapid advice guidelines, and in 2013 included these agents in the WHO Model Lists of Essential Medicines as part of the 'core list'. In line with WHO recommendations, the Southern African HIV Clinicians Society has strongly supported efforts to obtain access to flucytosine in updated clinical guidelines.
Article metrics loading...